About CROS NT
CROS NT is a Healthcare company based in Chapel Hill (United States) founded in 1992, and was acquired by Alira Health in June 2021. Data-centric CRO services are provided for pharma and medical devices. CROS NT has completed 1 acquisition, including Stat-Tech Services. Its Indian entity Cros Nt India Private Limited reported revenue of ₹3.24 Cr. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Emmes, Syneos Health and Veristat.
Company details
CROS NT is a contract research organisation serving the medical device and pharmaceutical industries. Service offering includes clinical data management, biostatistical programming, medical writing, safety, and pharmacovigilance. Areas of expertise include cardiovascular, neurology, dermatology, diabetes, diagnostics, imaging agents, hip implants, oncology, orthopaedics, respiratory, spinal implants, and urology. They offer their services through a range of technologies including EDC, eDiaries (eCOA), IWRS, Safety databases, and Visual Analytics. CROS NT also offers Risk-Based Monitoring services. The company has offices in the UK, Italy, Germany and India.
- Headquarters Chapel Hill, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website crosnt.com
- Social LinkedIn X
- Acquired by Alira Health (Jun 2021)
- Legal Name Cros Nt India Private Limited
- Date of Incorporation 16 May, 2017
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹3.24 Cr
FY 2020 · +15% YoY
- Indian entity net profit₹74.2 Lakh
FY 2020 · 23% margin
- Indian entity EBITDA₹1.12 Cr
FY 2020 · 35% margin
- Investors
- Investments & Acquisitions
- Acquired byAlira Health
(Jun 2021)
Associated legal entities of CROS NT
CROS NT operates through Cros Nt India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cros Nt India Private Limited CIN U72900KA2017FTC102949 | Active | 16 May 2017 | Bangalore, Karnataka | ₹3.2 Cr | 2 | View details |
Investors in CROS NT
CROS NT has secured backing from 1 investor. Prominent investors backing the company include Alira Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of advisory services, healthcare IT, market access, regulatory affairs, and other services | 1999 | alirahealth.com | Framingham, United States |
Investor details for CROS NT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cros Nt India Private Limited (CROS NT)
Cros Nt India Private Limited is the primary company behind CROS NT. The board of Cros Nt India Private Limited currently have 2 directors; the longest-serving is Paolo Morelli, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Paolo Morelli DIN 07676688 | Director | 16 May 2017 | 9 yrs 5 mo | Cros Nt India Private Limited |
| Nithiyanandhan Ananthakrishnan DIN 06724459 | Director | 16 May 2017 | 9 yrs 5 mo | Cros Nt India Private Limited |
Financials of CROS NT
Figures of Cros Nt India Private Limited, the primary company behind CROS NT, for FY 2020. Revenue was ₹3.24 Cr (+15% year on year). Net profit was ₹74.2 Lakh (23% margin). EBITDA was ₹1.12 Cr (35% margin).
- ₹3.24 CrRevenue · FY 2020 · +15% YoY
- ₹74.2 LakhNet profit · 23% margin
- ₹1.12 CrEBITDA · 35% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Cros Nt India Private Limited are on its company page.
Detailed financial statements for CROS NT
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CROS NT
CROS NT has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Stat-Tech Services.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Comprehensive ophthalmological services and laser vision correction are offered. | stattechservices.com | Chapel Hill, United States | 1996 | Sep 2013 | •••• |
Complete acquisition details for CROS NT
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CROS NT
3 dated milestones of CROS NT across 29 years, from founding to its latest funding, stage changes and deals.
- Founded CROS NT is founded.
- Acquisition Acquires Stat-Tech Services.
- Exit Acquired by Alira Health.
Competitors of CROS NT
CROS NT has 3 listed competitors in our database. They include Emmes, Syneos Health and Veristat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | 195 | Outsourced contract research organization services are provided to clients. | ||
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| veristat.com | 1994 | Southborough, United States | 7 | Clinical trials and regulatory submissions are supported as a CRO. |
Detailed competitors of CROS NT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CROS NT
Websites that share an audience with CROS NT (crosnt.com).
Websites whose visitors overlap most with CROS NT. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ecrscorp.com | 100% | 12.7K | #1,252,459 | View details | |
| proteogenex.com | 98% | 2.5K | #7,820,245 | View details | |
| richmondpharmacology.com | 97% | 8.1K | #4,561,453 | View details | |
| incresearch.com | 96% | View details | |||
crors.org.br | crors.org.br | 58% | #904,745 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as CROS NT (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cros Nt
Complete news archive for CROS NT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CROS NT
CROS NT was founded in 1992.
CROS NT is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
The primary company behind CROS NT, Cros Nt India Private Limited, reported revenue of ₹3.24 Cr for FY 2020, up 15% year on year.
CROS NT is a contract research organisation serving the medical device and pharmaceutical industries. Service offering includes clinical data management, biostatistical programming, medical writing, safety, and pharmacovigilance. Areas of expertise include cardiovascular, neurology, dermatology, diabetes, diagnostics, imaging agents, hip implants, oncology, orthopaedics, respiratory, spinal implants, and urology. They offer their services through a range of technologies including EDC, eDiaries (eCOA), IWRS, Safety databases, and Visual Analytics. CROS NT also offers Risk-Based Monitoring services. The company has offices in the UK, Italy, Germany and India.
CROS NT's top competitors include Emmes, Syneos Health and Veristat.
CROS NT has made 1 acquisition, including Stat-Tech Services.
CROS NT has 1 investor. Key investors include Alira Health.
CROS NT operates through Cros Nt India Private Limited.
Yes. CROS NT was acquired by Alira Health in June 2021.
The legal entities of CROS NT currently have 2 directors, including Paolo Morelli, Nithiyanandhan Ananthakrishnan.